S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
New York goes dark, then America. (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Urgent alert: open this for a huge profit potential (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
New York goes dark, then America. (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Urgent alert: open this for a huge profit potential (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
New York goes dark, then America. (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Urgent alert: open this for a huge profit potential (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
New York goes dark, then America. (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Urgent alert: open this for a huge profit potential (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Free Trial

Aura Biosciences (AURA) Competitors

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)
Free AURA Stock Alerts
$7.19
+0.13 (+1.84%)
(As of 04/19/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media

AURA vs. MGX, GLUE, CRBU, ALVO, MGTX, HUMA, AVXL, IVVD, LXEO, and TCRX

Should you be buying Aura Biosciences stock or one of its competitors? The main competitors of Aura Biosciences include Metagenomi (MGX), Monte Rosa Therapeutics (GLUE), Caribou Biosciences (CRBU), Alvotech (ALVO), MeiraGTx (MGTX), Humacyte (HUMA), Anavex Life Sciences (AVXL), Invivyd (IVVD), Lexeo Therapeutics (LXEO), and TScan Therapeutics (TCRX). These companies are all part of the "biological products, except diagnostic" industry.

Aura Biosciences vs.

Aura Biosciences (NASDAQ:AURA) and Metagenomi (NASDAQ:MGX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, profitability, analyst recommendations, earnings, dividends, risk, institutional ownership, media sentiment and valuation.

In the previous week, Aura Biosciences had 2 more articles in the media than Metagenomi. MarketBeat recorded 2 mentions for Aura Biosciences and 0 mentions for Metagenomi. Aura Biosciences' average media sentiment score of 1.28 beat Metagenomi's score of 0.00 indicating that Aura Biosciences is being referred to more favorably in the media.

Company Overall Sentiment
Aura Biosciences Positive
Metagenomi Neutral

Metagenomi has higher revenue and earnings than Aura Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aura BiosciencesN/AN/A-$76.41M-$1.92-3.74
Metagenomi$44.76M5.77-$68.25MN/AN/A

Metagenomi's return on equity of 0.00% beat Aura Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Aura BiosciencesN/A -42.20% -36.66%
Metagenomi N/A N/A N/A

Aura Biosciences currently has a consensus target price of $21.00, indicating a potential upside of 192.07%. Metagenomi has a consensus target price of $21.40, indicating a potential upside of 210.60%. Given Metagenomi's higher possible upside, analysts clearly believe Metagenomi is more favorable than Aura Biosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aura Biosciences
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Metagenomi
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00

Aura Biosciences received 5 more outperform votes than Metagenomi when rated by MarketBeat users. However, 100.00% of users gave Metagenomi an outperform vote while only 46.15% of users gave Aura Biosciences an outperform vote.

CompanyUnderperformOutperform
Aura BiosciencesOutperform Votes
12
46.15%
Underperform Votes
14
53.85%
MetagenomiOutperform Votes
7
100.00%
Underperform Votes
No Votes

96.8% of Aura Biosciences shares are held by institutional investors. 5.9% of Aura Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Metagenomi beats Aura Biosciences on 7 of the 12 factors compared between the two stocks.

Get Aura Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for AURA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AURA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AURA vs. The Competition

Export to Excel
MetricAura BiosciencesBiological Products IndustryMedical SectorNASDAQ Exchange
Market Cap$355.91M$2.47B$4.80B$7.30B
Dividend YieldN/A2.83%2.94%4.01%
P/E Ratio-3.7443.09269.1620.04
Price / SalesN/A360.642,456.8689.18
Price / CashN/A156.4847.1034.82
Price / Book1.573.654.554.16
Net Income-$76.41M-$49.12M$104.05M$214.20M
7 Day Performance-4.64%-8.70%-4.50%-3.54%
1 Month Performance-3.88%-10.53%-6.08%-4.09%
1 Year Performance-18.02%2.28%6.70%3.28%

Aura Biosciences Competitors List

Export to Excel
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MGX
Metagenomi
2.2788 of 5 stars		$10.42
+5.9%		$21.40
+105.4%		N/A$390.44M$44.76M0.00236Positive News
GLUE
Monte Rosa Therapeutics
2.1022 of 5 stars		$7.86
+4.7%		$11.00
+39.9%		-11.6%$394.18MN/A-2.98133Positive News
CRBU
Caribou Biosciences
1.4787 of 5 stars		$4.46
+2.3%		$22.50
+404.5%		-10.7%$402.83M$34.48M-3.08158
ALVO
Alvotech
0.1049 of 5 stars		$11.93
-0.7%		$12.67
+6.2%		+28.8%$372.81M$91.43M-4.911,026News Coverage
MGTX
MeiraGTx
3.8887 of 5 stars		$5.72
+2.7%		$25.67
+348.7%		-10.1%$367.34M$14.02M-3.89419News Coverage
Positive News
HUMA
Humacyte
2.0162 of 5 stars		$3.04
-1.9%		$8.00
+163.2%		+7.5%$362.00M$1.57M-2.84164Short Interest ↑
News Coverage
Gap Up
AVXL
Anavex Life Sciences
3.3424 of 5 stars		$4.39
flat		$40.00
+811.2%		-53.2%$360.46MN/A-8.1340
IVVD
Invivyd
2.9472 of 5 stars		$3.02
-1.3%		$11.33
+275.3%		+97.5%$360.05MN/A-1.6784Gap Down
High Trading Volume
LXEO
Lexeo Therapeutics
1.7213 of 5 stars		$13.45
+2.2%		$20.80
+54.6%		N/A$358.71M$650,000.000.0058News Coverage
TCRX
TScan Therapeutics
1.8355 of 5 stars		$7.45
+1.5%		$12.50
+67.8%		+229.5%$356.71M$21.05M-3.94154Analyst Report
Analyst Revision
News Coverage

Related Companies and Tools

Related Companies:
Top 10 Stock Comparisons
This page (NASDAQ:AURA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Biden’s $374B Giveaway Into This Sector
DTI
SHOCKING Crypto Leak…
Crypto 101 Media
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
How Biden has already won 2024
Porter & Company
Top 5 AI Stocks to Buy for 2024
Market Moving Trends